UK Biotech Company Renovo Scraps IPO

UK biotechnology company Renovo has scrapped its planned initial public offering in London due to tough market conditions, the company said. A spokeswoman for Renovo told Reuters: "The board, shareholders and management of Renovo have decided in light of current market conditions to postpone the planned initial public offering of Renovo as they believe there are currently better alternatives to generate further shareholder value."
Reuters